🩸 HematologySingle IV infusion (gene therapy)

    HEMGENIX

    Etranacogene Dezaparvovec

    HEMGENIX is a gene therapy for adults with hemophilia B that delivers a functional copy of the Factor IX gene to reduce or eliminate bleeding episodes.

    Form

    Single IV infusion (gene therapy)

    Uses

    2

    Side effects

    4

    Category

    Hematology

    01

    What is HEMGENIX used for?

    • Hemophilia B (Factor IX deficiency) in adults
    • Prevention of uncontrolled bleeding in severe or moderately severe hemophilia B
    02

    Etranacogene Dezaparvovec side effects

    Common side effects of Etranacogene Dezaparvovec include:

    Elevated liver enzymes
    Infusion-related reactions
    Fatigue
    Headache
    CommonModerateLess common
    03

    Etranacogene Dezaparvovec warnings & precautions

    • Risk of immune-mediated hepatotoxicity; monitor liver function tests
    • Long-term safety and durability of response still being established

    Loading FDA data…

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand HEMGENIX in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.